Literature DB >> 21453197

Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.

Mariana N Nikolova-Karakashian1, Michael B Reid.   

Abstract

SIGNIFICANCE: Sphingolipids are a class of bioactive lipids that regulate diverse cell functions. Ceramide, sphingosine, and sphingosine-1-phosphate accumulate in tissues such as liver, brain, and lung under conditions of cellular stress, including oxidative stress. The activity of some sphingolipid metabolizing enzymes, chiefly the sphingomyelinases, is stimulated during inflammation and in response to oxidative stress. Ceramide, the sphingomyelinase product, as well as the ceramide metabolite, sphingosine-1-phosphate, can induce the generation of more reactive oxygen species, propagating further inflammation. RECENT ADVANCES: This review article summarizes information on sphingolipid biochemistry and signaling pertinent to skeletal muscle and describes the potential influence of sphingolipids on contractile function. CRITICAL ISSUES: It encompasses topics related to (1) the pathways for complex sphingolipid biosynthesis and degradation, emphasizing sphingolipid regulation in various muscle fiber types and subcellular compartments; (2) the emerging evidence that implicates ceramide, sphingosine, and sphingosine-1-phosphate as regulators of muscle oxidant activity, and (3) sphingolipid effects on contractile function and fatigue. FUTURE DIRECTIONS: We propose that prolonged inflammatory conditions alter ceramide, sphingosine, and sphingosine-1-phosphate levels in skeletal muscle and that these changes promote the weakness, premature fatigue, and cachexia that plague individuals with heart failure, cancer, diabetes, and other chronic inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453197      PMCID: PMC3176343          DOI: 10.1089/ars.2011.3940

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  126 in total

1.  Effect of oxidative stress and acidosis on diaphragm contractile function.

Authors:  J M Lawler; C C Cline; Z Hu; J R Coast
Journal:  Am J Physiol       Date:  1997-08

2.  Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death.

Authors:  B Liu; N Andrieu-Abadie; T Levade; P Zhang; L M Obeid; Y A Hannun
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

3.  Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide.

Authors:  T I Gudz; K Y Tserng; C L Hoppel
Journal:  J Biol Chem       Date:  1997-09-26       Impact factor: 5.157

4.  Modulation of skeletal muscle Ca2(+)-release channel activity by sphingosine.

Authors:  D H Needleman; B Aghdasi; A B Seryshev; G J Schroepfer; S L Hamilton
Journal:  Am J Physiol       Date:  1997-05

5.  Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione.

Authors:  B Liu; Y A Hannun
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

6.  Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis.

Authors:  A Quillet-Mary; J P Jaffrézou; V Mansat; C Bordier; J Naval; G Laurent
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

7.  Identification, partial purification, and localization of a neutral sphingomyelinase in rabbit skeletal muscle: neutral sphingomyelinase in skeletal muscle.

Authors:  N Ghosh; R Sabbadini; S Chatterjee
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

8.  Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase.

Authors:  C M Li; S B Hong; G Kopal; X He; T Linke; W S Hou; J Koch; S Gatt; K Sandhoff; E H Schuchman
Journal:  Genomics       Date:  1998-06-01       Impact factor: 5.736

9.  Glycosphingolipids of skeletal muscle: II. Modulation of Ca2(+)-flux in triad membranes by gangliosides.

Authors:  J Müthing; U Maurer; S Weber-Schürholz
Journal:  Carbohydr Res       Date:  1998-02       Impact factor: 2.104

10.  Neutral sphingomyelinase 2 (nSMase2) is a phosphoprotein regulated by calcineurin (PP2B).

Authors:  Simone Filosto; William Fry; Anne A Knowlton; Tzipora Goldkorn
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

View more
  40 in total

Review 1.  Sphingolipids and lifespan regulation.

Authors:  Xinhe Huang; Bradley R Withers; Robert C Dickson
Journal:  Biochim Biophys Acta       Date:  2013-08-15

2.  Sphingomyelinase depresses force and calcium sensitivity of the contractile apparatus in mouse diaphragm muscle fibers.

Authors:  Leonardo F Ferreira; Jennifer S Moylan; Shawn Stasko; Jeffrey D Smith; Kenneth S Campbell; Michael B Reid
Journal:  J Appl Physiol (1985)       Date:  2012-02-23

Review 3.  Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

Authors:  S M De La Monte
Journal:  Panminerva Med       Date:  2012-09       Impact factor: 5.197

4.  Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.

Authors:  Kohsuke Tani; Keiji Tabuchi; Akira Hara
Journal:  Neurotox Res       Date:  2016-01       Impact factor: 3.911

5.  A chronic high-fat diet exacerbates contractile dysfunction with impaired intracellular Ca2+ release capacity in the skeletal muscle of aged mice.

Authors:  Hiroaki Eshima; Yoshifumi Tamura; Saori Kakehi; Ryo Kakigi; Ryota Hashimoto; Katsuhiko Funai; Ryuzo Kawamori; Hirotaka Watada
Journal:  J Appl Physiol (1985)       Date:  2020-03-26

6.  Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.

Authors:  David M Ryba; Chad M Warren; Chehade N Karam; Robert T Davis; Shamim A K Chowdhury; Manuel G Alvarez; Maximilian McCann; Chong Wee Liew; David F Wieczorek; Peter Varga; R John Solaro; Beata M Wolska
Journal:  Circ Heart Fail       Date:  2019-11-05       Impact factor: 8.790

Review 7.  Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewed.

Authors:  Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  Small-hairpin RNA and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction.

Authors:  Philip D Coblentz; Bumsoo Ahn; Linda F Hayward; Jeung-Ki Yoo; Demetra D Christou; Leonardo F Ferreira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

9.  Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content.

Authors:  Hyacinth M Empinado; Gergana M Deevska; Mariana Nikolova-Karakashian; Jeung-Ki Yoo; Demetra D Christou; Leonardo F Ferreira
Journal:  Eur J Heart Fail       Date:  2014-03-04       Impact factor: 15.534

10.  Neutral sphingomyelinase-2 is a redox sensitive enzyme: role of catalytic cysteine residues in regulation of enzymatic activity through changes in oligomeric state.

Authors:  P Patrick Dotson; Alexander A Karakashian; Mariana N Nikolova-Karakashian
Journal:  Biochem J       Date:  2015-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.